Aspirin 'could cut breast cancer risk by 20%'
Taking aspirin could significantly reduce the risk of developing breast cancer, a new study suggests.
With over 100 women diagnosed with the cancer in Britain every day, the news offers fresh hope for the prevention and treatment of the disease.
Recent studies have already indicated that taking aspirin regularly could help prevent strokes and heart attacks, on top of its intended role of stopping pain.
Now scientists have concluded aspirin could offer ‘significant protection’ against breast cancer and cut the risk of contracting the disease by 20%.
Ian Fentiman, who led the study, explained that aspirin could also be used to treat women with breast cancer by aiding hormone treatments to be as effective as possible.
However, experts are still unsure as to the quantities that should be taken and warn women not to start taking aspiring or nonsteroidal anti-inflammatory drugs (NSAIDs) until the long-term side effects are known.
Cancer charities welcomed the news, but reiterated the warning over side effects.
Dr Kat Arney, from Cancer Research UK, commented: ‘Drugs like aspirin are often touted as ‘wonder-drugs’ and we have seen repeatedly from studies like this that there can be a range of positive effects.
‘But, as with any drug there can be significant side effects from long term or heavy use – such as stomach ulcers – so we certainly wouldn’t recommend that people take large doses without medical advice.’